Uptake of ranibizumab but not bevacizumab into uveal melanoma cells correlates with a sustained decline in VEGF-A levels and metastatic activities

Ayseg├╝l Tura, Vera E. Pawlik, Martin Rudolf, Justus S. Ernesti, Jan Niklas Stutzer, Salvatore Grisanti, Mahdy Ranjbar*

*Corresponding author for this work
2 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Uptake of ranibizumab but not bevacizumab into uveal melanoma cells correlates with a sustained decline in VEGF-A levels and metastatic activities'. Together they form a unique fingerprint.

Medicine & Life Sciences